Revenue segments as reported by the company.

Cannabis revenue

Distribution revenue

Beverage alcohol revenue

Wellness revenue

Adult-use

Canada - Medical

International - Medical

Bulk

Hemp

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Impairment of Assets

Litigation settlement

Transaction costs

Change in fair value of contingent consideration

Restructuring costs

Other than temporary change in fair value of convertible notes receivable

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Tilray Brands

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia, and Latin America. The firm is focused on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment consists of hemp seed, hemp foods, and broad spectrum hemp extract containing CBD, which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Earnings data Q1 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Tilray Brands reports record revenue and optimistic outlook for 2025

Tilray Brands achieved remarkable financial performance in Q4 2024, driven by strategic acquisitions and a focus on innovation. Despite challenges like price compression, the company remains optimistic about future growth opportunities. Tilray's commitment to quality products and innovation positions it well for continued success in the market.

Tilray Brands reports record Q1 revenue growth and global expansion

Tilray Brands delivered a robust performance in Q1 2025, showcasing strong revenue growth, margin improvement, and strategic expansion across its diversified product portfolio.
While facing challenges in a competitive landscape and evolving regulatory environment, Tilray's financial strength, international growth initiatives, and focus on innovation position it well for future success.
By capitalizing on opportunities in wellness products, expanding into new beverage categories, and leveraging strategic partnerships, Tilray is poised for continued growth and market leadership.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Tilray Brands, Inc. is a global cannabis-lifestyle and consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. The Cannabis Business segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution Business segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage Alcohol Business segment refers to the production, marketing, and sale of beverages. The Wellness Business segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

HEXO Corp

Neither HEXO stock's technical trajectory, nor the company's subpar fundamentals, supports a long position now. The post Agreement With Tilray Isn't Necessarily a Boon for Hexo appeared first on InvestorPlace.

Agreement With Tilray Isn't Necessarily a Boon for Hexo

The business opportunity provided by Tilray is still bright, meanwhile the TLRY stock has already gone through a lifetime of whipsaws. The post Tilray Stock Should Recover Its Footing in Due Time appeared first on InvestorPlace.

Tilray Stock Should Recover Its Footing in Due Time

It hasn't proven that its business model is sustainable yet.

3 Reasons Why Now Isn't the Time to Buy Tilray Stock

Aurora Cannabis

Canopy Growth

Cronos Group

The move would open up the New York metro region to the cannabis industry.

Legal Cannabis Sales to Begin April 21 in New Jersey. What It Means for Weed Stocks.

Agrify

Akerna Corp

Lexaria Bioscience

OrganiGram Holdings Inc.

The Valens Co

Welcome back to our weekly series, Schaeffer's Cannabis Stock News Update, where we recap what happened in the world of marijuana stocks, and look at how the cannabis industry is shaping up as we roll through 2022.

7 Marijuana Stocks Heating Up This Week

Good things could be on the horizon when a stock surpasses the 50-Day simple moving average. How should investors react?

Tilray Brands, Inc. (TLRY) Recently Broke Out Above the 50-Day Moving Average

TLRY stock is in the doldrums and could stay that way until Tilray can figure out how to produce positive free cash flow selling cannabis. The post Tilray Stock Is Stuck In Neutral Until Cash Flow Turns Positive appeared first on InvestorPlace.

Tilray Stock Is Stuck In Neutral Until Cash Flow Turns Positive

What good is a profit if it's not sustainable or due to the company's own operations?

3 Reasons Tilray's Q3 Results Weren't That Impressive

Tilray Brands Inc. (NASDAQ: TLRY) has announced a financial and commercial partnership definitive agreement with Hexo Corp (NASDAQ: HEXO). This strategic partnership creates a collaboration deal for product innovation that include optimization of Cannabis 2.0 products and Cannabis 3.0 Wellness products.

Tilray Brands and Hexo sign definitive commercial and financial partnership agreement

SNDL Inc.

Hexo and Tilray will make a joint effort to cut costs, and investors think this deal is a hit.

Why Hexo, Tilray, and Sundial Stocks Popped on Tuesday

Canadian cannabis companies Tilray (TLRY) and Hexo (HEXO) are teaming up to better tackle the marijuana market and their stocks are rising! The post TLRY, HEXO Stocks: 7 Things to Know as Canadian Cannabis Kings Join Forces appeared first on InvestorPlace.

TLRY, HEXO Stocks: 7 Things to Know as Canadian Cannabis Kings Join Forces

Medical and consumer cannabis producer Tilray (NASDAQ: TLRY) stock has been an abysmal performer as shares collapsed to a low of $4.78 from its high of $300 after its IPO in September of 2018.

Tilray Stock Has Better Days Ahead

Share of Hexo Corp. HEXO, +6.97% HEXO, +10.77% rose about 6% on Wednesday after Tilray Brands Inc. trly said it would acquire Hexo's remaining $193 million senior secured convertible note. Tilray said the deal would give it a significant equity stake in Hexo, as well as a seat on the company's board; also Tilray will name a board observer.

Tilray buys Hexo debt and inks alliance

-- Canada's Top Two Cannabis Market Leaders to Join Forces, Strengthening Operations and Unlocking up to US$80 Million of Shared Cost Synergies -- -- Strategic Alliance Establishes Collaboration Agreement for Product Innovation, Including Optimizing Cannabis 2.0 Categories (Pre-Rolls, Beverages and Edibles), as well as Cannabis 3.0 Wellness Products --

Tilray Brands Announces Definitive Agreement With Hexo Corp. Related to Hexo's Senior Secured Convertible Note

Flora Growth Corp

Intercure Ltd

PepsiCo

Welcome back to our weekly series,  Schaeffer's Cannabis Stock News Update , where we recap what happened in the world of marijuana stocks, and look at how the cannabis industry is shaping up as we kick off 2022.

5 Cannabis Stocks to Watch Alongside MORE Act Momentum

Tilray stock received a boost recently as the US marijuana legalization cadence moved forward in the House of Representatives.

Is Tilray Stock A Buy, Sell, Or Hold After Earnings?

Legalizing pot in the U.S. could still be more difficult than some think.

Why Tilray, Canopy Growth, and Aurora Cannabis Stocks Dropped Early Monday

High Tide

Village Farms International

Are You Taking Advantage Of The Current Market? The post Are Top Canadian Stocks A Buy Right Now? How Active Traders Are Day Trading The Volatility appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Are Top Canadian Stocks A Buy Right Now? How Active Traders Are Day Trading The Volatility

A strong earnings report wasn't enough to overcome more macro issues.

Why Tilray Shares Have Been Sinking This Week

BioXcel Therapeutics

Merck

Could health care stocks be the play amidst the current volatility in markets?

Best Stocks To Buy Now? 3 Health Care Stocks For Your List

Trulieve Cannabis Corp.

Trulieve reported excellent revenues and profitability for FQ4'21, while Tilray posted impressive net income for FQ3'22.

Trulieve Vs. Tilray: Legalization May Not Be A Game Changer After All

Cannabis Stocks: Near-Term Headwinds Don't Matter Much (Podcast Transcript)

The stock is down more than 7% this year but up more than 20% this month.

Why Tilray Shares Dropped 10.1% on Thursday

TLRY stock posted strong third quarter results, feeding into its long-term bullish case. The post Tilray's Earnings Are in, Here's What You Should Know appeared first on InvestorPlace.

Tilray's Earnings Are in, Here's What You Should Know

Tilray Reports Positive Earnings: Look Beyond The Headline Numbers

News for Tilray Brands Stock (TLRY)